Ceftriaxone therapy for staphylococcal osteomyelitis: a review.
Ceftriaxone, although less active than standard antistaphylococcal agents, is potentially useful in the treatment of osteomyelitis. Thirty-one patients with osteomyelitis due to Staphylococcus aureus were identified, 22 of whom were treated with ceftriaxone and 9 with other agents. Of those patients treated with ceftriaxone, 17 were cured; all treatment failures were associated with chronic osteomyelitis and continued presence of necrotic bone or infected hardware. It is concluded that ceftriaxone is effective in the ambulatory treatment of S. aureus osteomyelitis.
Guglielmo
B J
BJ
Department of Clinical Pharmacy, School of Pharmacy, University of California San Francisco, San Francisco, CA 94143-0622, USA. bjg@itsa.ucsf.edu
Luber
A D
AD
Paletta
D
D
Jacobs
R A
RA
D000328:Adult; D000368:Aged; D000553:Ambulatory Care; D002443:Ceftriaxone / Q000627:therapeutic use*; D002511:Cephalosporins / Q000627:therapeutic use*; D006801:Humans; D008875:Middle Aged; D010019:Osteomyelitis / Q000188:drug therapy* / Q000382:microbiology; D012189:Retrospective Studies; D013203:Staphylococcal Infections / Q000188:drug therapy* / Q000382:microbiology; D013211:Staphylococcus aureus / Q000302:isolation & purification; D016896:Treatment Outcome
D002511:Cephalosporins; D002443:Ceftriaxone